Articles tagged with: BDSI
FDA meeting on BEMA Granisetron due on March 17 (Nasdaq:BDSI)
BEMA Granisetron is a product candidate that has been developed by BioDelivery Services International, Inc. (Nasdaq:BDSI). According to the company, this product can reduce vomiting and nausea.
Why Does This Stock Continue To Drop After Great News? (ARDM, HEB, BDSI)
I find it odd thatAradigm Corporation(OTC:ARDM) stock price dropped the day after Zogenix, Inc. was granted approval of the Sumavel™ DosePro. ARDM gets a $4 Million milestone payment upon first commercial sale and royalty payments …
FDA’s Target Date For Aradigm Corporation (ARDM, HEB, DSCO, LLY, BDSI)
Aradigm Corporation (ARDM) is pending a FDA decision on their drug Liposomal Ciprofloxacin. Lets see if the FDA meets their target date. The FDA has recently misses some important target dates with Hemispherx BioPharma, Inc (Public, AMEX:HEB), Discovery …
